Muscarinic cholinergic induced secretin subsensitivity in rat isolated pancreatic acini. Effects on amylase release, cyclic adenosine monophosphate and inositol phosphate formation
- PMID: 2470085
- DOI: 10.1097/00006676-198902000-00011
Muscarinic cholinergic induced secretin subsensitivity in rat isolated pancreatic acini. Effects on amylase release, cyclic adenosine monophosphate and inositol phosphate formation
Abstract
In this study, dispersed rat pancreatic acini exhibited secretin subsensitivity in their capacity to release amylase after preexposure to increasing concentrations of the muscarinic cholinergic agonist carbamylcholine. The present study also explores the potential mechanisms involved in this cellular desensitization phenomenon. Secretin subsensitivity of pancreatic acini pre-exposed to 10(-4) M carbamylcholine was observed only at secretin concentrations above 10(-8) M. The desensitized cells had not recovered 3 h after the cholinergic agonist exposure. In these acini, the adenylate cyclase pathway remained unaltered because cholera toxin, forskolin, and 8-Br-cAMP still induced weak, but normal, amylase release when compared with control acini. In vivo administration of pertussis toxin failed to protect the dispersed pancreatic acini against carbamylcholine-induced secretin subsensitivity. Moreover, cAMP production by these acini in response to secretin, cholera toxin, and forskolin was similar to that observed in control acini. Secretin stimulation of inositol phosphate (InsP1, InsP2, InsP3) production after carbamylcholine pre-exposure remained equivalent to that observed in acini that had never been exposed to the cholinergic agonist. Thus, after muscarinic cholinergic agonist exposure, pancreatic acini showed secretin subsensitivity in their capacity to release enzyme. This phenomenon appears to result from modifications at post-second messenger loci.
Similar articles
-
Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms.Proc Natl Acad Sci U S A. 1987 May;84(10):3146-50. doi: 10.1073/pnas.84.10.3146. Proc Natl Acad Sci U S A. 1987. PMID: 2437575 Free PMC article.
-
Effect of somatostatin on cholecystokinin-induced amylase release in rat pancreatic acini.Pancreas. 2001 Jul;23(1):102-8. doi: 10.1097/00006676-200107000-00015. Pancreas. 2001. PMID: 11451139
-
EGF inhibits secretagogue-induced cAMP production and amylase secretion by Gi proteins in pancreatic acini.Am J Physiol. 1995 Nov;269(5 Pt 1):G676-82. doi: 10.1152/ajpgi.1995.269.5.G676. Am J Physiol. 1995. PMID: 7491958
-
Effects of increased intracellular cAMP on carbachol-stimulated zymogen activation, secretion, and injury in the pancreatic acinar cell.Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G235-43. doi: 10.1152/ajpgi.00334.2004. Epub 2004 Sep 30. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15458924 Free PMC article.
-
Interactions of lithium and drugs that affect signal transduction on behaviour in rats.Eur Neuropsychopharmacol. 1999 Sep;9(5):385-97. doi: 10.1016/s0924-977x(99)00009-7. Eur Neuropsychopharmacol. 1999. PMID: 10523045 Review.
Cited by
-
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Ann Surg. 2004 Nov;240(5):757-73. doi: 10.1097/01.sla.0000143252.02142.3e. Ann Surg. 2004. PMID: 15492556 Free PMC article. Review.
-
Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF.Int J Pancreatol. 1994 Aug;16(1):37-44. doi: 10.1007/BF02925608. Int J Pancreatol. 1994. PMID: 7528761
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources